Stock Taper
| DATE | TYPE | RATIO |
|---|---|---|
| 2026-05-11 | Reverse | 1:30 |
| 2026-01-16 | Reverse | 1:40 |
Aspire Biopharma Holdings, Inc., founded in 2021 in Florida, develops innovative sublingual delivery technologies for medications like Instaprin and various other formulations for cardiology, pain, sleep, vitamins, and more.

BUZZ BOMB™ is Aspire Biopharma’s flagship sublingual caffeine supplement, quickly absorbed and popular, with 2 million units sold and a new brand identity and e-commerce platform to meet rising demand.
| Icon | PRODUCT | Q3-2025 | Q1-2026 |
|---|---|---|---|
![]() | Nutraceutical Products | $1.94K | $28.35K ▲ |
| Map | REGION | Q1-2026 | Q2-2026 |
|---|---|---|---|
![]() | UNITED STATES | $27.14K | $58.03K ▲ |
![]() | International | — | $4.69K |
![]() | NonUS | $729 | — |
![]() | CANADA | $480 | $384 ▼ |
Overall rating: C
| PEER | PRICE | |
|---|---|---|
PALI | $1.90 | COMPARE |
ANNA | $2.76 | COMPARE |
DARE | $2.07 | COMPARE |
BCTX | $7.28 | COMPARE |
CRIS | $0.85 | COMPARE |
CTXR | $0.90 | COMPARE |
PCSA | $3.46 | COMPARE |
ADTX | $0.84 | COMPARE |